DE3568944D1 - Pharmaceutical composition for oral administration containing, on the one hand, as active principle the 9-alpha,11-beta dichloro-16-alpha methyl 21-oxycarbonyldicyclohexylmethyloxy pregna-1,4-diene 3,20-dione and, on the other hand, an inert pharmaceutical excipient which is able to permit the activity of the product in the rectum or in the colon and the utilization of the active principle in the preparation of such a pharmaceutical composition - Google Patents

Pharmaceutical composition for oral administration containing, on the one hand, as active principle the 9-alpha,11-beta dichloro-16-alpha methyl 21-oxycarbonyldicyclohexylmethyloxy pregna-1,4-diene 3,20-dione and, on the other hand, an inert pharmaceutical excipient which is able to permit the activity of the product in the rectum or in the colon and the utilization of the active principle in the preparation of such a pharmaceutical composition

Info

Publication number
DE3568944D1
DE3568944D1 DE8585400612T DE3568944T DE3568944D1 DE 3568944 D1 DE3568944 D1 DE 3568944D1 DE 8585400612 T DE8585400612 T DE 8585400612T DE 3568944 T DE3568944 T DE 3568944T DE 3568944 D1 DE3568944 D1 DE 3568944D1
Authority
DE
Germany
Prior art keywords
hand
pharmaceutical composition
active principle
alpha
rectum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8585400612T
Other languages
English (en)
Inventor
Francoise Delevallee
Roger Deraedt
Simone Jouquey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Application granted granted Critical
Publication of DE3568944D1 publication Critical patent/DE3568944D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE8585400612T 1984-04-03 1985-03-28 Pharmaceutical composition for oral administration containing, on the one hand, as active principle the 9-alpha,11-beta dichloro-16-alpha methyl 21-oxycarbonyldicyclohexylmethyloxy pregna-1,4-diene 3,20-dione and, on the other hand, an inert pharmaceutical excipient which is able to permit the activity of the product in the rectum or in the colon and the utilization of the active principle in the preparation of such a pharmaceutical composition Expired DE3568944D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8405222A FR2561919B1 (fr) 1984-04-03 1984-04-03 Composition pharmaceutique constituee d'une part, a titre de principe actif, par la 9a,11b-dichloro 16a-methyl 21-oxycarbonyldicyclohexyl methyloxy pregna-1,4-diene 3,20-dione et d'autre part, par un excipient pharmaceutique inerte apte a permettre l'action du produit dans le rectum ou le colon

Publications (1)

Publication Number Publication Date
DE3568944D1 true DE3568944D1 (en) 1989-04-27

Family

ID=9302777

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585400612T Expired DE3568944D1 (en) 1984-04-03 1985-03-28 Pharmaceutical composition for oral administration containing, on the one hand, as active principle the 9-alpha,11-beta dichloro-16-alpha methyl 21-oxycarbonyldicyclohexylmethyloxy pregna-1,4-diene 3,20-dione and, on the other hand, an inert pharmaceutical excipient which is able to permit the activity of the product in the rectum or in the colon and the utilization of the active principle in the preparation of such a pharmaceutical composition

Country Status (16)

Country Link
US (1) US4614736A (de)
EP (1) EP0161144B1 (de)
JP (1) JPS60224615A (de)
AT (1) ATE41604T1 (de)
AU (1) AU571073B2 (de)
CA (1) CA1226817A (de)
DE (1) DE3568944D1 (de)
DK (1) DK164478C (de)
FR (1) FR2561919B1 (de)
GR (1) GR850815B (de)
HU (1) HU196122B (de)
IL (1) IL74642A (de)
MA (1) MA20388A1 (de)
OA (1) OA07978A (de)
PT (1) PT80214B (de)
ZA (1) ZA851927B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909559D0 (en) * 1989-04-26 1989-06-14 Smith Kline French Lab Pharmaceutical compositions
US5578576A (en) * 1994-09-02 1996-11-26 Dalhousie University Method and composition for treating intestinal wounds or ulcers
US20050059583A1 (en) * 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
US7135455B2 (en) * 2004-11-15 2006-11-14 Allergan, Inc Methods for the therapeutic use of cyclosporine components
US7151085B2 (en) 2004-11-15 2006-12-19 Allergan, Inc. Therapeutic methods using cyclosporine components

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2462443A1 (fr) * 1979-07-26 1981-02-13 Roussel Uclaf Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
FR2533928A1 (fr) * 1982-10-05 1984-04-06 Roussel Uclaf Nouveaux derives dichlores de la serie du 16a-methyl pregnane, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
CA1226817A (fr) 1987-09-15
EP0161144B1 (de) 1989-03-22
FR2561919A1 (fr) 1985-10-04
JPS60224615A (ja) 1985-11-09
US4614736A (en) 1986-09-30
DK164478B (da) 1992-07-06
ZA851927B (en) 1986-04-30
IL74642A (en) 1988-09-30
OA07978A (fr) 1987-01-31
DK146785D0 (da) 1985-04-01
PT80214A (en) 1985-05-01
HU196122B (en) 1988-10-28
DK164478C (da) 1992-11-23
HUT44436A (en) 1988-03-28
GR850815B (de) 1985-07-23
ATE41604T1 (de) 1989-04-15
PT80214B (en) 1987-02-17
IL74642A0 (en) 1985-06-30
AU571073B2 (en) 1988-03-31
MA20388A1 (fr) 1985-10-01
DK146785A (da) 1985-10-04
EP0161144A1 (de) 1985-11-13
FR2561919B1 (fr) 1986-12-19
AU4080085A (en) 1985-10-10

Similar Documents

Publication Publication Date Title
EP0243002A3 (en) Pharmaceutical composition for the treatment of periodontal diseases
AU598020B2 (en) Cosmetic composition
EP0147261A3 (en) Medicine and medicinal composition for the treatment and the prevention of skin affections involving an inflammation process
EP0151989A3 (en) Means for the treatment of cardiac diseases
EP0137543A3 (en) Pharmaceutical composition for the therapy of peripheral arteriopathies
HUT38897A (en) Process for producing pharmaceutically active substituted benzamides and pharmaceutical compositions containing them as active agents
AU551900B2 (en) Anthralin compositions for treatment of skin diseases
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
ZA898605B (en) Compositions for topical treatment of skin diseases
IE802589L (en) Anti-inflammatory pharmaceutical composition containing¹rosmarinic acid
AU2690684A (en) Methods and pharmaceutical compositions for the treatment of hyperplastic diseases of the skin
EP0334853A4 (de) Weiche steroide mit anti-entzündungswirkung.
DE3568944D1 (en) Pharmaceutical composition for oral administration containing, on the one hand, as active principle the 9-alpha,11-beta dichloro-16-alpha methyl 21-oxycarbonyldicyclohexylmethyloxy pregna-1,4-diene 3,20-dione and, on the other hand, an inert pharmaceutical excipient which is able to permit the activity of the product in the rectum or in the colon and the utilization of the active principle in the preparation of such a pharmaceutical composition
AU550675B2 (en) Pharmaceutical compositions for the treatment of skin
GB2162748B (en) Medicinal composition for the treatment or prevention of acne by oral administration
DE2963141D1 (en) New compounds related to dilignols, compounds related to dilignols for use in the treatment of liver deseases and pharmaceutical compositions containing them
MY101916A (en) Etoposide oral dosage form.
ES8504665A1 (es) Metodo de preparar derivados de p-acilaminofenol
GB2093345B (en) A topical use composition for the treatment of seborrhea affections of the human scalp
HUT44073A (en) Process for producing purified human angiogene factor and pharmaceutical compositions containing them
Confavreux et al. Trends in European Multiple Sclerosis Research
PT94787A (pt) Processo de preparacao de composicoes farmaceuticas para administracao transdermica de corticosteroides e de compostos com actividade fisiologica semelhante
ES8307810A1 (es) "procedimiento para la preparacion de nuevos 2-metilen-lh-2,3,5,6-tetrahidro-imidazoni,2-a imidazoles".
MY102687A (en) Novel galenical comprising a somatostatin formulations.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee